HIV-related non-Hodgkin's lymphoma (HIV-NHL) in the era of highly active antiretroviral therapy (HAART): Some still unanswered quetions for clinical management

Annals of Oncology

Volumn 15, Issue 7, 2004, Pages 993-995

  Spina, M ^a   Tirelli, U ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; RITUXIMAB; VINCRISTINE;

B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTINUOUS INFUSION; DRUG FATALITY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; EDITORIAL; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERMETHOD COMPARISON; NEUTROPENIA; NONHODGKIN LYMPHOMA; OPPORTUNISTIC INFECTION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME; VIRUS LOAD;

ANTI-RETROVIRAL AGENTS; ANTIBODIES, MONOCLONAL; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BURKITT LYMPHOMA; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; HUMANS; INFUSION PUMPS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, NON-HODGKIN;

EID: 4143134340     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/mdh281     Document Type: Editorial

References (22)

1. Kaplan LD, Straus DJ, Testa MA et al. Low-dose compared to standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997; 336: 1641-1648.
2. Gisselbrecht C, Oksenhendler E, Tirelli U et al. Human immunodeficiency virus-related lymphoma treatment with intensive combination chemotherapy: French-Italian Cooperative Group. Am J Med 1993; 95: 188-196.
3. Besson C, Goubar A, Gabarre J et al. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 2001; 98: 2339-2344.
4. Gerard L, Galicier L, Maillard A et al. Systemic non-Hodgkin's lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. AIDS 2002; 30: 478-484.
5. Vaccher E, di Gennaro G, Schioppa O et al. Highly active antiretroviral therapy (HAART) significantly improves disease free survival (DFS) in patients (Pts) with HIV-related non-Hodgkin's lymphoma (HIV-NHL) treated with chemotherapy (CT). Proc Am Soc Clin Oncol 2001; 20: 281a (Abstr 1122).
6. Fisher RI, Gaynor ER, Dahlberg S et al. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med 1993; 328: 1002-1006.
7. Gisselbrecht C, Spina M, Gabarre J et al. Therapy of HIV-related non-Hodgkin's lymphoma: an European multicentric randomized study in patients stratified according to their prognostic factors: preliminary results. J Acquir Immune Defic Syndr 1997; 14: A53 (Abstr 149).
8. Coiffier B, Lepage E, Briere J et al. CHOP chemotherapy plus Rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-242.
9. Sparano JA, Wiernik PH, Hu X et al. A pilot trial of infusional cyclophosphamide, doxorubicin and etoposide plus didanosine and filgrastim in patients with HIV-associated non-Hodgkin's lymphoma. J Clin Oncol 1996; 14: 3026-3035.
10. Little RF, Pittaluga S, Grant N et al. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 2003; 101: 4653-4659.
11. Spina M, Sparano JA, Jaeger U et al. Rituximab and chemotherapy is highly effective in patients with CD20-positive non-Hodgkin's lymphoma and HIV infection. AIDS 2003; 17: 137-138.
12. Boué F, Gabarre J, Gisselbrecht C, et al. CHOP chemotherapy plus rituximab in HIV patients with high grade lymphoma - Results of an ANRS trial. Proc Am Soc Hematol 2002; 470a, (Abstr 1824).
13. Kaplan LD, Scadden DT. for the AIDS Malignancies Consortium. No benefit from rituximab in a randomized phase III trial of CHOP with or without rituximab for patients with HIV-associated non-Hodgkin's lymphoma: AIDS malignancies consortium study 010. Proc Am Soc Clin Oncol 2003; 22: 564 (Abstr 2268).
14. Cortes J, Thomas D, Rios A et al. Hyperfractionated cyclophosphamide, vincristine, doxorubicin and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 2002; 94: 1492-1499.
15. Astrow AB, Tarabay G, Salerno VE et al. Long-term survival in patients with human immunodeficiency virus-associated small non-cleaved cell lymphoma: the role of short course intensive chemotherapy. Hematol Oncol 2003; 21: 131-140.
16. Wang ES, Straus DJ, Teruya-Feldstein J et al. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 2003; 98: 1196-1205.
17. Tirelli U, Errante D, Spina M et al. Second-line chemotherapy in human immunodeficiency virus-related non-Hodgkin's lymphoma: evidence of activity of a combination of etoposide, mitoxantrone and prednimustine in relapsed patients. Cancer 1996; 77: 2127-2131.
18. Levine AM, Tulpule A, Tessman D et al. Mitoguazone therapy in patients with refractory or relapsed AIDS-realted lymphoma: results from a multicenter phase II trial. J Clin Oncol 1997; 15: 1094-1103.
19. Spina M, Vaccher E, Juzbasic S et al. Human immunodeficiency virus-related non-Hodgkin's lymphoma: activity of infusional cyclophosphamide, doxorubicin and etoposide as second-line chemotherapy in 40 patients. Cancer 2001; 92: 200-206.
20. Gabarre J, Azar N, Autran B et al. High-dose chemotherapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 2000; 355: 1071-1072.
21. Molina A, Zaia J, Krishnan A. Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation. Blood Rev 2003; 17: 249-258.
22. Re A, Cattaneo C, Michieli M et al. High-dose therapy and autologous peripheral-blood stem-cell (PBSC) transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 2003; 21: 4423-4427.